ELVN
Earnings in 6 days · May 13, 2026 · Before open
Signal
Leaning Bearish1!
Price
1
Move-0.91%Quiet session
Volume
1
Volume0.6× avgNormal activity
Technical
1
RSIRSI 74Overbought
PRICE
Prev Close
41.58
Open
41.98
Day Range40.76 – 42.33
40.76
42.33
52W Range14.79 – 48.53
14.79
48.53
78% of range
VOLUME & SIZE
Avg Volume
557.4K
FUNDAMENTALS
P/E Ratio
EPS (TTM)
Div Yield
No dividend
Performance
1D
-0.91%
5D
-0.15%
1M
+5.80%
3M
+40.04%
6M
+125.14%
YTD
+167.53%
1Y
+109.24%
Best: YTD (+167.53%)Worst: 1D (-0.91%)
Quick Read
TrendInsufficient MA data
Momentum
BEARISH
thin 0% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 28.7 · FCF negative
Neutral
Key MetricsTTM
Market Cap$2.51B
Revenue TTM$0.00
Net Income TTM-$103.69M
Free Cash Flow-$70.46M
Gross Margin0.0%
Net Margin0.0%
Operating Margin0.0%
Return on Equity-24.2%
Return on Assets-21.8%
Debt / Equity0.00
Current Ratio28.66
EPS TTM$-1.83

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong3 concern
45/100
Liquidity
28.66Strong
Leverage
0.00Strong
Coverage
0.0xConcern
ROE
-24.2%Concern
ROIC
-26.0%Concern
Cash
$99MStrong
ANALYST COVERAGE6 analysts
BUY
-5.3%downside to target
L $39.00
Med $39.00consensus
H $52.00
Buy
6100%
6 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
RSI RangeRSI 74 — Overbought, caution
~
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 28.66 — healthy liquidity
Upcoming Events
EEarnings ReportMay 8, 2026
Tomorrow
DEx-Dividend DateAug 5, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 105 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 31.5%

+37.3% vs SMA 50 · +80.6% vs SMA 200

Momentum

RSI74.1
Overbought — pullback risk
MACD+3.36
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$48.53+17.8%
Current
$41.20
EMA 50
$31.07-24.6%
EMA 200
$24.01-41.7%
52W Low
$14.79-64.1%
52-Week RangeNear 52-week high
$14.7978th %ile$48.53
Squeeze SetupVolume-based
Distribution Pressure

Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.

20-Day Money Flow
Acc days:3
Dist days:3
Edge:Even
Volume Context
Avg Vol (50D)542K
Recent Vol (5D)
245K-55%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 5 analysts
Analyst revisions:EPS↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$10000
$10000$10000
-$1.74
±2%
Moderate3
FY2026(current)
$10000
$10000$10000
+0.0%-$2.02
±18%
Moderate4
FY2027
$10000
$10000$10000
+0.0%-$2.65
High5
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryELVN
Last 8Q
+8.0%avg beat
Beat 6 of 8 quartersMissed 2 Estimates rising
+7%
Q2'24
+29%
Q3'24
+8%
Q4'24
+13%
Q1'25
-12%
Q2'25
+8%
Q3'25
+26%
Q4'25
-14%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $238K sold · 30d window
Collins Helen LouiseCHIEF MEDICAL …
$6K
Apr 17
SELL
Collins Helen LouiseCHIEF MEDICAL …
$115K
Apr 17
SELL
Collins Helen LouiseCHIEF MEDICAL …
$117K
Apr 17
SELL
Collins Helen LouiseCHIEF MEDICAL …
$1.4M
Mar 25
SELL
Collins Helen LouiseCHIEF MEDICAL …
$139K
Mar 17
SELL
Collins Helen LouiseCHIEF MEDICAL …
$306K
Mar 10
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Pictet Asset Management Holding SA
930K
2
Candriam S.C.A.
594K
3
Capricorn Fund Managers Ltd
369K
4
UBS Group AG
284K
5
Bank of New York Mellon Corp
120K
6
Nuveen, LLC
106K
7
TEMA ETFS LLC
43K
8
Skopos Labs, Inc.
12K
News & Activity

ELVN News

20 articles · 4h ago

About

enliven therapeutics focuses on the discovery and development of next generation small molecule treatments for cancer. we are backed by top-tier life science venture funds. we seek experienced and passionate drug hunters to join our team as we grow our r&d organization in boulder, co.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwELO
ELVN
$41.20-0.91%$2.5B1500
$68.09+0.00%$13.3B+12626.1%1500
$92.25+0.00%$11.7B+3288.2%1500
$539.73+0.00%$11.5B1500
$222.28+0.00%$11.4B1500
$79.14+0.00%$10.5B1500
$175.93-0.01%$10.3B+1871.5%1500
Sector avg-0.13%+5928.6%1500